GBMA

Global Biosimilars Week 11-15 Nov
2024-11-11 - 2024-11-15
The IGBA’s 5th annual Global Biosimilars Week is taking place from November 11-15, 2024. The mission of this social media campaign is to raise awareness of the powerful and lifechanging impacts of biosimilar medicines.
The theme this year is Advancing Access to Biosimilars. There have been great strides made in the approval, market acceptance and adoption of biosimilar medicines over the past two decades, but progress has been varied around the globe.
The GBMA, on behalf of their international counterparts, invite patients, healthcare professionals, government organisations and other interested parties in Australia to show their support of biosimilars throughout the week by using the hashtag #GlobalBiosimilarsWeek.
To learn more, visit the IGBA’s global site: Global Biosimilars Week
Register now for the GBW Webinar:
Streamlining the Regulatory Process to Advance Access to Biosimilars
With an effort to highlight the importance of collaboration among healthcare professionals, patients, stakeholders, and policymakers, this global webinar will focus on Streamlining Regulatory Requirements to advance access to biosimilars, with expert discussions on the key barriers to biosimilar uptake in different regions and explore strategies to overcoming these obstacles.
Register to be part of this important conversation during Global Biosimilars Week and contribute to the global movement for biosimilar access.

Advancing Access to Biosimilar Medicines
Hear from Adrian van den Hoven, Chair of the IGBA, introducing this year’s theme:

Questions? Please reach out to the GBMA via our ‘Contact us’ page.

Global Biosimilars Week, 3 - 7 November 2025
2025-11-03 - 2025-11-07
On behalf of the International Generic and Biosimilar Medicines Association (IGBA), the GBMA is pleased to officially announce that the 6th Annual Global Biosimilars Week social media awareness campaign will take place from November 3 to 7, 2025.
This year’s theme is Biosimilars: A Wise Investment for Global Health – better access to biosimilar medicines will help more people live healthier lives worldwide.
We warmly invite all stakeholders in Australia to show their support of biosimilars throughout the week by using the hashtags #GlobalBiosimilarsWeek and #GBW25.
To support participation, a social media toolkit is available for download with campaign logos, customisable image templates, sample posts and other resources. Please note that because this is an international resource, some of the messaging may need tailoring to ensure they are appropriate for the Australian market.

Global Webinar – Wed 5th November
As the world faces increasing health challenges, biosimilar medicines offer a promising solution to enhance accessibility, affordability, and sustainability of healthcare systems worldwide, which are all important pillars to meet the UN Sustainable Development Goals for Health by 2030

To learn more, visit the IGBA’s global site: Global Biosimilars Week 2025
Questions? Please reach out to the GBMA via our ‘Contact us’ page.

GBMA Summit - No patient left waiting: end the era of medicine shortages
2026-02-04 09:30 - 14:00 (Australia/Sydney) | Parliament House, Australia
Thank you to everyone who attended the recent GBMA Summit – No patient left waiting: ending the era of medicine shortages
Government, industry and healthcare leaders came together at the GBMA Summit to explore some of the contributors to medicine shortages and discuss how healthcare stakeholders can together chart a path toward sustainable access to medicines for Australians.
The program opened with key insights to set the context for the day, including global perspectives and keynote addresses from the Minister for Health, Disability and Ageing The Hon. Mark Butler MP and Shadow Minister for Health and Aged Care Senator the Hon. Anne Ruston, before moving through three focused sessions.

Session 1: Barriers, examining how Australia’s reimbursement settings can contribute to unintended disruptions;
Session 2: Opportunity and agility, exploring globally informed, action-oriented solutions for effective reporting and stronger system responsiveness; and
Session 3: Access and processes, identifying practical reforms to streamline regulation without compromising safety.

Confirmed speakers:

The Hon. Mark Butler MP, Minister for Health, Disability and Ageing
Senator the Hon. Anne Ruston, Shadow Minister for Health and Aged Care
Hon. Prof. Jane Halton AO PSM, Independent Chair, GBMA
Marnie Peterson, Chief Executive Officer, GBMA
Assoc. Prof. Tom Simpson, President, Adpha
Luke Escombe, Ambassador for Crohn’s and Colitis Australia
Hayley Tamborini, Chief Commercial Officer, Arrotex
Clint Holland, Country Head, Sandoz
Steve Graham, General Manger, Commercial (Business Development), DBG Health
Dr Stephen Jenkins, Director Government & Corporate Affairs APAC, Teva Pharma
Sue MacLeman, Chair and Non-Executive Director, Medicines Australia
Nick Henderson, First Assistant Secretary, Medicines Regulation Division, TGA
Elizabeth Cuming, Chief Executive Officer, NPSA
Anthony Tassone, Victoria Branch Vice President & National Councilor, The Pharmacy Guild of Australia
Chad Rieger, Head of Medical Affairs and Policy, Australia and New Zealand, Sandoz
Fleur Douy, Senior Regulatory Affairs Manager, Arrotex
Chris Campbell, General Manager Policy and Program Delivery, PSA
